virus Government infection patient

What is Regeneron’s covid treatment? Trump claims the drug cured him

Reading now: 681
www.livemint.com

Combination of two monoclonal antibodiesREGN-COV2 is a combination of two monoclonal antibodies and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19."To develop REGN-COV2, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company's VelocImmune® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19," the pharma company statement said.

Late last month, Regeneron reported preliminary results from a trial showing that the cocktail could reduce virus levels in coronavirus patients outside of the hospital.Free drug for AmericansIn a statement, the company said that under its.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA